0000950170-24-066687.txt : 20240530
0000950170-24-066687.hdr.sgml : 20240530
20240530163425
ACCESSION NUMBER: 0000950170-24-066687
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240530
DATE AS OF CHANGE: 20240530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maeusli Heinz Christoph
CENTRAL INDEX KEY: 0001788919
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36569
FILM NUMBER: 241006013
MAIL ADDRESS:
STREET 1: SCHUETZENWEG 3
CITY: ENGELBURG
STATE: V8
ZIP: 9032
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantheus Holdings, Inc.
CENTRAL INDEX KEY: 0001521036
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 352318913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
BUSINESS PHONE: 978 671-8001
MAIL ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
FORMER COMPANY:
FORMER CONFORMED NAME: Lantheus MI Holdings, Inc.
DATE OF NAME CHANGE: 20110517
4
1
ownership.xml
4
X0508
4
2024-05-28
0001521036
Lantheus Holdings, Inc.
LNTH
0001788919
Maeusli Heinz Christoph
C/O LANTHEUS HOLDINGS, INC.
201 BURLINGTON ROAD, SOUTH BUILDING
BEDFORD
MA
01730
true
false
false
false
true
Common Stock
2024-05-28
4
M
false
17481
16.17
A
49032
D
Common Stock
2024-05-28
4
S
false
7.326
77.71
D
41706
D
Common Stock
2024-05-28
4
S
false
12307
78.95
D
29399
D
Common Stock
2024-05-28
4
S
false
5959
79.67
D
23440
D
Common Stock
2024-05-28
4
S
false
100
80.29
D
23340
D
Stock Option (right to buy)
16.17
2024-05-28
4
M
false
17481
0.00
D
2020-06-19
2029-12-13
Common Stock
17481
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.27 to $78.12, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.28 to $79.26, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.29 to $80.22, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
/s/ Eric M. Green, attorney-in-fact
2024-05-30